Alit Stark-Inbar

CPM conditioned pain modulation dAEs device-related adverse events HIPAA health insurance portability and accountability act MOH medication overuse headache REN remote electrical neuromodulation RWE real-world evidence INTRODUCTION Migraine is a highly prevalent, chronic, neurological disease, affecting up to 15% of the global population.1, 2 It is characterized by debilitating headaches and associated symptoms that can significantly impair an individual's quality of life, productivity, and...

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Preventive treatment is essential for effectively managing migraine and mitigating its burden [1]; however, adequate migraine prevention remains an unmet need [2]. The American Headache Society (AHS) Consensus Statement emphasizes the importance of preventive treatment in individuals with frequent disabling migraine attacks, contraindication to or overuse of acute medications or adverse events (AEs) [3].